| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 1616 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 1616 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1616 |
| 3 | DOXORUBICIN | 1210 |
| 4 | CARBOPLATIN | 1086 |
| 5 | RITUXIMAB | 1025 |
| 6 | METHOTREXATE SODIUM | 977 |
| 7 | METHOTREXATE | 916 |
| 8 | DEXAMETHASONE | 913 |
| 9 | DEXAMETHASONE 1.5 MG | 913 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IODINE 2% | 1 | 0.1000 |
| 1 | THIOGUANINE | 138 | 0.0649 |
| 2 | INDIUM IN -111 PENTETREOTIDE | 7 | 0.0547 |
| 3 | CLOFARABINE | 71 | 0.0310 |
| 4 | THIOTEPA | 301 | 0.0308 |
| 5 | PENTAMIDINE ISETHIONATE | 38 | 0.0302 |
| 6 | TRABECTEDIN | 64 | 0.0272 |
| 7 | TALAZOPARIB | 48 | 0.0259 |
| 8 | PIVMECILLINAM | 4 | 0.0213 |
| 9 | PENPULIMAB | 2 | 0.0204 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 2332 |
| 1 | Alkylating Drug [EPC] | 2213 |
| 2 | Corticosteroid [EPC] | 2000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1948 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1164 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1078 |
| 6 | Kinase Inhibitor [EPC] | 1037 |
| 7 | Microtubule Inhibitor [EPC] | 980 |
| 8 | Topoisomerase Inhibitor [EPC] | 956 |
| 9 | Thalidomide Analog [EPC] | 489 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 168 | 0.0287 |
| 1 | Topoisomerase Inhibitor [EPC] | 956 | 0.0124 |
| 2 | Actinomycin [EPC] | 24 | 0.0109 |
| 3 | Prostacycline [EPC] | 9 | 0.0096 |
| 4 | Alkylating Drug [EPC] | 2213 | 0.0091 |
| 5 | Platinum-based Drug [EPC] | 2332 | 0.0085 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 181 | 0.0084 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 1948 | 0.0071 |
| 8 | Histone Deacetylase Inhibitor [EPC] | 24 | 0.0062 |
| 9 | Microtubule Inhibitor [EPC] | 980 | 0.0059 |